Tutogen

Quality defects and donor tissue history must be more carefully monitored to increase public acceptance if the biologics market is to succeed, according to a new report by business intelligence experts GBI Research. The new report* refers to the emerging pattern emerging in drug recalls over recent years, which shows that vaccines and immunoglobulins, in [...]